Get these stocks while they're near their 52-week lows.
Compare JAZZ Stock to Peers
|Symbol||Last Price||Market Cap||% Δ 1 Yr||% Δ 5 Yr|
News & Analysis: Jazz Pharmaceuticals
You'll definitely want to check out these biotech bargains.
Neither of them needs to sell marijuana to consumers to succeed.
Investors have been selling off the stock since the company released its earnings report earlier this month.
JAZZ earnings call for the period ending June 30, 2021.
Jazz Pharma is not the most popular drugmaker, but it is definitely worth a second look.
Yes, but not in the way you might think.
They are great options whether you are investing for the short or long term.
The developer of cannabis-based medications is now under new ownership.
JAZZ earnings call for the period ending March 31, 2021.